Director/PDMR Shareholding
Victrex plc announced that Chief Executive Officer Dr. James Routh sold 28,331 ordinary shares at £7.03 per share on February 16, 2026, to cover tax liabilities arising from the award of 13,035 Deferred Bonus Buyout Shares and the exercise of 47,031 nil cost share options. Following these transactions, Dr. Routh retains 36,255 ordinary shares, including 6,886 from the bonus award and 24,849 from the exercised options.
Select text to share a quote on X · sign in to keep highlights & notes in your VCT notes
On 16 February 2026, Dr James Routh, Chief Executive Officer of Victrex plc (Victrex), sold sufficient shares in Victrex to cover the associated income tax and NI liabilities arising from the award of 13,035 Deferred Bonus Buyout Shares on 12 February 2026 and retained the balance of 6,886 shares. He also exercised 47,031 nil cost share options granted under Parts 1 and 2 of the 2023 LTIP Buy-Out Award granted on 12 February 2026 and sold sufficient shares to cover the associated income tax and NI liabilities, retaining the balance of 24,849 shares, at a price of £7.03 per ordinary share.
As a result of these transactions, Dr. Routh holds 36,255 ordinary shares in Victrex including 4,520 shares purchased on 5 December 2025, prior to becoming Chief Executive Officer on 1 January 2026.
| a) | Name | Dr James Routh |
| 2 | Reason for the notification | |
| a) | Position/status | Chief Executive Officer |
| b) | Initial notification /Amendment | Initial Notification |
| a) | Name | Victrex plc |
| b) | LEI | 213800UYNPHAUNHPXL67 |
| a) | Description of the financial instrument, type of instrument | Ordinary Shares of 1p each- |
| Identification code | GB0009292243 | |
| b) | Nature of the transaction | 1. Sale of sufficient Deferred Bonus Buyout Shares awarded 12 February 2026 to cover costs . Retained balance of 6,886 shares 2. Exercise of 47,031 nil cost share options granted under Parts 1 and 2 of the 2023 LTIP Buy-Out Award granted 12 February 2026 and sale of sufficient shares to cover costs. Retained balance of 24,849. |
| c) | Price(s) and volume(s) | |
| Price(s) | Volume(s) | |
| £ 7.03 | 28,331 | |
| d) | Aggregated information | n/a single transaction |
| - Aggregated volume | ||
| - Price | ||
| e) | Date of the transaction | 2026-02-16 |
| f) | Place of the transaction | London Stock Exchange |
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.